Making Medicines Affordable A National Imperative (2018) / Chapter Skim
Currently Skimming:
Appendix C: Glossary
Appendix C: Glossary
Pages 183-188
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 183... ...
Food and Drug Administration, including vaccines, blood and blood components, allergenic compounds, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.
|
From page 184... ...
-- The U.S. Food and Drug Administration designation for a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product.
|
From page 185... ...
. health insurance risk pool -- Special health insurance coverage programs for individuals whose health status limits their access to coverage in the private individual health insurance market often due to a pre-existing condition.
|
From page 186... ...
The U.S. Food and Drug Administration generally requires new drugs to be tested in phase III trials before they can be put on the market.
|
From page 187... ...
Public Health Service Act provides discounts to qualifying hospital systems for the purpose of subsidizing accessible and affordable medical care among low-income and vulnerable patients. specialty drugs -- General term for medications that feature one or more of the following characteristics: highly expensive, complex molecularly (often derived from living cells)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.